Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Cyclically Adjusted FCF per Share: ¥0.38 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603456 Zhejiang Jiuzhou Pharmaceutical Co Ltd SHSE:603456
96 GF Score
Price ¥16.49
GF Value ¥16.60
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted FCF per Share?

Zhejiang Jiuzhou Pharmaceutical Co SHSE:603456 +4.96% 96 Cyclically Adjusted FCF per Share is ¥0.38 as of Jun. 2026. GuruFocus rates SHSE:603456 with a GF Score™ of 96/100 and a GF Value™ of ¥16.60 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zhejiang Jiuzhou Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Jun. 2026 was ¥0.395. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.38 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Zhejiang Jiuzhou Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 65.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 76.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Zhejiang Jiuzhou Pharmaceutical Co was 76.50% per year. The lowest was 76.50% per year. And the median was 76.50% per year.

As of today (2026-08-25), Zhejiang Jiuzhou Pharmaceutical Co's current stock price is ¥16.49. Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was ¥0.38. Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 43.39.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhejiang Jiuzhou Pharmaceutical Co was 1684.33. The lowest was 36.79. And the median was 172.10.


Zhejiang Jiuzhou Pharmaceutical Co  (SHSE:603456) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=16.49/0.38
=43.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhejiang Jiuzhou Pharmaceutical Co was 1684.33. The lowest was 36.79. And the median was 172.10.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.06 0.10 0.16 0.33

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.28 0.33 0.32 0.38

SHSE:603456 vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:603456
96GF Score
Zhejiang Jiuzhou Pharmaceutical Co Ltd SHSE:603456
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Jiuzhou Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Jiuzhou Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.395/116.0564*116.0564
=0.395

Current CPI (Jun. 2026) = 116.0564.

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.073 102.400 0.083
201612 0.015 102.600 0.017
201703 -0.015 103.200 -0.017
201706 -0.005 103.100 -0.006
201709 0.067 104.100 0.075
201712 0.081 104.500 0.090
201803 -0.023 105.300 -0.025
201806 0.090 104.900 0.100
201809 0.115 106.600 0.125
201812 -0.108 106.500 -0.118
201903 0.070 107.700 0.075
201906 0.114 107.700 0.123
201909 -0.018 109.800 -0.019
201912 0.138 111.200 0.144
202003 0.040 112.300 0.041
202006 -0.141 110.400 -0.148
202009 0.359 111.700 0.373
202012 -0.137 111.500 -0.143
202103 -0.130 112.662 -0.134
202106 0.075 111.769 0.078
202109 0.117 112.215 0.121
202112 0.061 113.108 0.063
202203 0.288 114.335 0.292
202206 0.075 114.558 0.076
202209 0.519 115.339 0.522
202212 -0.265 115.116 -0.267
202303 0.280 115.116 0.282
202306 0.076 114.558 0.077
202309 0.249 115.339 0.251
202312 -0.114 114.781 -0.115
202403 -0.407 115.227 -0.410
202406 0.238 114.781 0.241
202409 0.078 115.785 0.078
202412 0.223 114.893 0.225
202503 0.121 115.116 0.122
202506 0.506 114.907 0.511
202509 0.394 115.471 0.396
202512 0.288 115.832 0.289
202603 -0.017 116.303 -0.017
202606 0.395 116.056 0.395

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.38 mean?
Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) has a Cyclically Adjusted FCF per Share of ¥0.38 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors.
Is Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Zhejiang Jiuzhou Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.38. Overall, Zhejiang Jiuzhou Pharmaceutical Co has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted FCF per Share compare to ZTS?
Zhejiang Jiuzhou Pharmaceutical Co's Cyclically Adjusted FCF per Share of ¥0.38 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors. Zhejiang Jiuzhou Pharmaceutical Co's current Cyclically Adjusted FCF per Share is ¥0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Jiuzhou Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.60, compared to a current price of ¥16.49 — trading 0.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.38. Zhejiang Jiuzhou Pharmaceutical Co's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456), the current Cyclically Adjusted FCF per Share is ¥0.38 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥16.49 is trading 0.7% below its estimated GF Value™ of ¥16.60. GuruFocus considers Zhejiang Jiuzhou Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:603456:

  • Cyclically Adjusted FCF per Share: ¥0.38
  • GF Value™: ¥16.60 vs. price of ¥16.49 (0.7% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603456 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Jiuzhou Pharmaceutical Co Business Description

Address No. 99 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, and Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
96GF Score

Get the complete analysis for SHSE:603456

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.49
Price
¥16.60
GF Value